Top Page
People's Insurance Co (Group) of China
(OTC:1339)
People's Insurance Co (Group) of China (1339) vs. S&P 500 (SPY)
People's Insurance Co (Group) of China Business Overview & Revenue Model
People's Insurance Co (Group) of China Financial Statement Overview
| Breakdown | ||||
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 501.76B | 614.64B | 592.01B | 579.77B | 549.88B | Gross Profit |
| 501.76B | 614.64B | 592.01B | 579.77B | 549.88B | EBIT |
| 0.00 | 37.71B | 27.03B | 23.69B | 19.22B | EBITDA |
| 42.98B | 42.86B | 45.90B | 41.75B | 23.31B | Net Income Common Stockholders |
| 22.77B | 34.43B | 30.37B | 28.23B | 31.28B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 21.87B | 21.36B | 21.79B | 23.13B | 23.95B | Total Assets |
| 1.56T | 1.51T | 1.38T | 1.26T | 1.13T | Total Debt |
| 40.26B | 46.20B | 47.43B | 60.34B | 51.83B | Net Debt |
| 18.39B | 24.83B | 25.65B | 37.22B | 27.89B | Total Liabilities |
| 1.23T | 1.21T | 1.08T | 982.51B | 885.93B | Stockholders Equity |
| 242.35B | 221.77B | 219.26B | 202.48B | 183.45B |
| Cash Flow | Free Cash Flow | |||
| 66.98B | 65.08B | 110.35B | 59.83B | 31.91B | Operating Cash Flow |
| 70.55B | 71.65B | 72.73B | 31.87B | 36.81B | Investing Cash Flow |
| -70.93B | -73.28B | -81.56B | -51.37B | -6.30B | Financing Cash Flow |
| -11.48B | 8.56B | -35.86B | 21.11B | -15.18B |
People's Insurance Co (Group) of China Technical Analysis
People's Insurance Co (Group) of China Peers Comparison
People's Insurance Co (Group) of China Corporate Events
The People’s Insurance Company (Group) of China Limited announced the successful passing of resolutions at its 2025 first extraordinary general meeting held on April 29, 2025. Key resolutions included the approval of the remuneration scheme for directors and supervisors for 2023 and the election of new directors to the board. The meeting complied with relevant legal and regulatory requirements, and no shareholders were required to abstain from voting.
The People’s Insurance Company (Group) of China Limited has proposed amendments to its Articles of Association, which were approved by its board of directors. These amendments are subject to approval at the company’s general meeting and by the National Financial Regulatory Administration. The changes aim to align the company’s governance with relevant laws and regulations, potentially impacting its operational framework and stakeholder relations.
The People’s Insurance Company (Group) of China Limited reported significant financial growth in its first quarterly report of 2025, with a 12.8% increase in total operating income and a 43.4% rise in net profit attributable to the owners compared to the previous year. This growth reflects a strong operational performance and improved market positioning, benefiting stakeholders and enhancing the company’s financial stability.
The People’s Insurance Company (Group) of China Limited has announced the scheduling of its 2025 First Quarter Results Announcement. This event will be conducted through a text interaction session on April 30, 2025, allowing investors to engage and have their questions addressed. This initiative reflects the company’s commitment to transparency and active communication with its stakeholders, potentially enhancing its market position and investor relations.
The People’s Insurance Company (Group) of China Limited has announced a board meeting scheduled for April 29, 2025, to review and approve the unaudited financial results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder interests.
The People’s Insurance Company (Group) of China Limited announced an estimated net profit increase for the first quarter of 2025, projecting a rise of 30% to 50% compared to the previous year. This growth is attributed to strategic reforms and innovations, improved underwriting performance, and significant investment returns, reflecting the company’s alignment with national strategies and its focus on high-quality development.
The People’s Insurance Company (Group) of China Limited has announced the convening of its 2025 first extraordinary general meeting (EGM) to be held on April 29, 2025. The meeting will address several key resolutions, including the approval of the remuneration scheme for directors and supervisors for 2023, and the election of new non-executive and independent non-executive directors to the board. This meeting is significant for stakeholders as it will influence the company’s governance and strategic direction, potentially impacting its market positioning and operational effectiveness.
The People’s Insurance Company (Group) of China Limited announced its audited annual results for the year ended December 31, 2024, reporting a significant increase in profit before tax to RMB 69,232 million from RMB 33,557 million in 2023. The company’s total operating income rose to RMB 622,220 million, driven by higher insurance revenue and net investment gains, reflecting a strong financial performance and improved market positioning.
The People’s Insurance Company (Group) of China Limited has announced a final ordinary cash dividend of RMB 0.117 per share for the financial year ending December 31, 2024. The payment date for this dividend is set for August 30, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders, potentially impacting its market positioning and investor relations positively.
The People’s Insurance Company (Group) of China Limited has announced key changes in its board of directors, appointing Mr. Xu Xiang as a non-executive director and Ms. Yeung Cheung Ying and Mr. Jia Ruo as independent non-executive directors. These appointments are part of the company’s ongoing efforts to strengthen its governance and strategic direction. Additionally, the company has accepted the resignation of Mr. Miao Fusheng, who has been a significant contributor to the company’s governance and strategic initiatives since 2020. His departure is due to age, and he will continue to fulfill his duties until a new director is appointed.
The People’s Insurance Company (Group) of China Limited has announced that it will release its 2024 annual results on March 27, 2025, followed by an annual results presentation on March 28, 2025. This presentation will be accessible both onsite and via webcast, allowing investors to engage with the company’s leadership and have their questions addressed. This event is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market position and investor confidence.
The People’s Insurance Company (Group) of China Limited has announced a board meeting scheduled for March 27, 2025, to discuss and approve the annual results for the year ending December 31, 2024. The meeting will also consider the potential payment of a final dividend, which could impact shareholder returns and reflect the company’s financial health.
The People’s Insurance Company (Group) of China Limited announced the resignation of Mr. Li Zhuyong from his roles as executive director, vice president, and other key positions due to a change of work. Mr. Li’s tenure was marked by significant contributions to corporate governance improvements, risk compliance, and the company’s domestic and international listing efforts. His departure is acknowledged with gratitude by the board, highlighting his dedication and impact on the company’s strategic goals.
The People’s Insurance Co (Group) of China has announced its updated list of directors and their roles within the company. The announcement includes the composition of five special committees under the board of directors, which are crucial for the company’s governance and strategic decision-making. This update is significant as it outlines the leadership structure and the individuals responsible for various strategic and operational functions, potentially impacting the company’s future direction and stakeholder interests.
The People’s Insurance Company (Group) of China Limited has announced the appointment of Mr. Gao Pingyang as an independent non-executive director, effective from February 7, 2025, following approval from the National Financial Regulatory Administration. This appointment, coinciding with the retirement of Mr. Ko Wing Man, is part of the company’s efforts to enhance its board’s governance and strategic direction. Mr. Gao will serve on the Nomination and Remuneration Committee and the Risk Management & Consumers’ Rights and Interests Protection Committee, reflecting the company’s ongoing commitment to robust corporate governance and risk management practices.
The People’s Insurance Co (Group) of China has announced the list of its directors and their respective roles and functions. This announcement outlines the structure of the board, including executive, non-executive, and independent non-executive directors, as well as the formation of five special committees to enhance governance and strategic oversight. The new board composition is expected to strengthen the company’s operational efficiency and governance capabilities, potentially impacting its market positioning positively.